Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиViking Therapeutics Мультипликаторы 2011-2024 | VKTX
Мультипликаторы по годам Viking Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-26.8 | -27.3 | -6.5 | -13436.7 | -17.6 | -21.7 | -6.6 | -1.5 | -0.6 | - | - | - | - |
P/S |
- | - | - | 49453.4 | - | - | - | - | - | - | - | - | - |
EPS |
-0.9 | -0.9 | -0.7 | -0.5 | -0.4 | -0.4 | -0.8 | -0.9 | -3.7 | -5.2 | - | - | - |
EV (Enterprise Value) |
2.27 млрд | 1.86 млрд | 338 млн | 502 млн | 452 млн | 459 млн | 135 млн | 25.9 млн | 19.2 млн | 24.4 млн | 431 тыс. | 105 тыс. | - |
EBITDA per Share |
-1.07 | -0.92 | -0.72 | -0.000535 | -0.451 | -0.376 | -0.743 | -0.794 | -3.53 | - | - | - | - |
EV/EBITDA |
-5.2 | -12917.5 | -13.7 | -21.0 | -6.7 | -1.8 | -0.7 | - | - | - | - | ||
PEG |
-0.0 | -0.0 | -0.0 | -134.57 | -3.34 | -0.42 | -0.54 | -0.02 | -0.01 | - | - | - | - |
P/B |
6.6 | 12.9 | 1.8 | 2.2 | 1.6 | 1.6 | 10.0 | 2.8 | 1.5 | - | - | - | - |
P/CF |
-31.4 | -38.8 | -7.5 | -24.4 | -18.3 | -25.6 | -9.2 | -2.0 | -1.5 | - | - | - | - |
ROE % |
-24.65 | -47.39 | -27.24 | -0.02 | -9.30 | -7.41 | -152.83 | -183.17 | -268.24 | - | - | - | - |
ROA % |
-23.31 | -40.86 | -26.10 | -0.02 | -9.07 | -7.30 | -93.02 | -101.35 | -151.59 | - | - | - | - |
ROCE % |
-28.86 | -48.00 | -27.58 | -0.02 | -11.78 | -8.79 | -141.63 | -171.82 | -89.11 | - | - | - | - |
Current Ratio |
18.4 | 7.3 | 24.0 | 21.1 | 41.8 | 66.4 | 2.5 | 2.2 | 7.7 | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Viking Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.23 | -0.19 | -0.25 | - | -0.21 | -0.23 | -0.21 | - | -0.17 | -0.2 | -0.19 | - | -0.13 | -0.13 | -0.13 | - | -0.08 | -0.11 | -0.07 | - | -0.11 | -0.13 | -0.08 | - | -0.22 | -0.21 | -0.23 | - | -0.2 | -0.22 | -0.4 | - | -0.53 | -1.07 | -1.4 | - | -0.06 | -5.4 | -0.08 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.27 | -0.24 | -0.26 | - | -0.21 | -0.23 | -0.21 | - | -0.17 | -0.2 | -0.19 | - | -0.14 | -0.15 | -0.15 | - | -0.1 | -0.13 | -0.09 | - | -0.12 | -0.13 | -0.11 | - | -0.17 | -0.21 | -0.22 | - | -0.17 | -0.21 | -0.36 | - | -0.48 | -0.36 | -0.11 | - | -0.25 | -5.15 | -0.08 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-36.09 | -40.40 | -45.97 | -29.81 | -36.02 | -31.81 | -28.10 | -18.96 | -22.76 | -20.35 | -17.43 | -11.68 | -13.75 | -12.02 | -10.87 | -6.61 | -8.83 | -8.98 | -8.45 | -5.65 | -50.95 | -94.03 | -130.20 | -122.50 | -169.84 | -171.88 | -179.38 | -137.85 | -192.14 | -199.09 | -243.32 | -209.89 | -208.71 | -153.24 | 39.86 | 105.17 | 105.17 | 103.99 | 1.03 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-33.09 | -36.67 | -40.13 | -25.98 | -31.88 | -20.06 | -26.52 | -17.97 | -21.59 | -19.31 | -16.57 | -11.13 | -13.15 | -11.54 | -10.51 | -6.45 | -8.63 | -8.80 | -8.31 | -5.56 | -33.14 | -58.52 | -79.70 | -74.56 | -100.75 | -99.37 | -101.40 | -76.28 | -106.95 | -111.44 | -136.98 | -118.61 | -127.22 | -105.14 | -802.86 | -764.79 | -764.79 | -756.19 | -7.52 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-39.31 | -42.54 | -47.08 | -30.12 | -36.41 | -32.09 | -28.33 | -19.19 | -23.22 | -20.96 | -18.39 | -12.85 | -15.53 | -14.18 | -13.29 | -8.58 | -11.07 | -10.87 | -9.74 | -6.42 | -41.27 | -73.64 | -108.30 | -99.93 | -140.44 | -146.09 | -153.50 | -125.44 | -157.30 | -148.65 | -123.76 | -54.79 | -48.89 | -11.14 | 120.09 | 118.69 | 118.69 | 112.79 | 1.08 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
26.5 | 27.5 | 9.0 | 7.3 | 10.8 | - | 15.3 | 24.0 | 19.8 | 18.5 | 19.4 | 21.1 | 21.1 | 21.1 | 21.1 | 39.8 | 39.8 | 39.8 | 39.8 | 66.3 | 66.3 | 66.3 | 66.3 | 2.6 | 2.6 | 2.6 | 2.6 | 2.2 | 2.2 | 2.2 | 2.2 | 2.3 | 2.3 | 2.3 | 2.3 | 0.1 | 0.1 | 0.1 | 0.1 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD